(Q28268075)

2

0 references

T A Sheldon

3

0 references

A House

4

0 references

P Watson

5

0 references

A Long

6

0 references

J Mason

A rating scale for depression

7

0 references

language of work or name

English

0 references

publication date

13 March 1993

0 references

published in

The BMJ

0 references

volume

306

0 references

issue

6879

0 references

page(s)

683-7

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Meta-analysis in clinical trials

20 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

20 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Development of a Rating Scale for Primary Depressive Illness

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Enhancing effective and acceptable purchaser and provider decisions: overview and methods

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Fluoxetine efficacy vs comparative drugs: an overview

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Fluoxetine, a highly selective serotonin reuptake inhibitor: a review of preclinical studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Recognition and management of depression in general practice: consensus statement

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A controlled comparison of fluoxetine and amitriptyline in depressed out-patients.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A comparative trial of a new antidepressant, fluoxetine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Fluoxetine versus trazodone in the treatment of outpatients with major depression.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind study of fluoxetine and imipramine in major depression.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A multicentre open trial of fluoxetine in depressed out-patients in Belgium.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A placebo- and imipramine-controlled study of paroxetine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Selective serotonin reuptake inhibitors

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Sleep and paroxetine: a comparison with mianserin in elderly depressed patients

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1677099

Meta-analysis and multiple publication of clinical trial reports

27 November 2018

1 reference

12 December 2020

A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group

1 reference

12 December 2020

Paroxetine in the treatment of depression--a randomized comparison with amitriptyline

1 reference

12 December 2020

Treatment of major affective disorder with fluvoxamine

1 reference

12 December 2020

Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin

1 reference

12 December 2020

Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders

1 reference

12 December 2020

A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders

1 reference

12 December 2020

Fluoxetine versus nomifensine in outpatients with neurotic or reactive depressive disorder

1 reference

12 December 2020

Fluoxetine versus imipramine

1 reference

12 December 2020

A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression

1 reference

12 December 2020

Fluoxetine in depressed patients: a comparison with imipramine

1 reference

12 December 2020

Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders

1 reference

12 December 2020

Fluoxetine versus clomipramine in major depressive disorders

1 reference

12 December 2020

Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders

1 reference

12 December 2020

A comparison of statistical methods for combining event rates from clinical trials

1 reference

12 December 2020

Fluoxetine vs amitriptyline in the treatment of depressed out-patients

1 reference

12 December 2020

A comparative trial of fluoxetine versus trazodone in outpatients with major depression

1 reference

12 December 2020

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

12 December 2020

A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

1 reference

12 December 2020

Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial

1 reference

12 December 2020

Fluoxetine Versus Trazodone in Depressed Geriatric Patients

1 reference

12 December 2020

A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression

1 reference

12 December 2020

Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study

1 reference

12 December 2020

A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression

1 reference

12 December 2020

Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression

1 reference

12 December 2020

Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study

1 reference

12 December 2020

A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major Depression

1 reference

12 December 2020

Double-blind comparison of bupropion and fluoxetine in depressed outpatients

1 reference

12 December 2020

Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

1 reference

12 December 2020

A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients

1 reference

12 December 2020